Drug Profile


Alternative Names: FGF-10; HG 03400; Keratinocyte growth factor-2; KGF-2

Latest Information Update: 04 Feb 2004

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator GlaxoSmithKline; Human Genome Sciences
  • Class Fibroblast growth factors
  • Mechanism of Action Fibroblast growth factor stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Mucositis; Neutropenia; Ulcerative colitis; Varicose ulcer

Most Recent Events

  • 04 Feb 2004 Discontinued - Phase-II for Neutropenia in USA (unspecified route)
  • 04 Feb 2004 Discontinued - Phase-II for Ulcerative colitis in USA (unspecified route)
  • 04 Feb 2004 Discontinued - Phase-II for Mucositis in USA (IV)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top